BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  Arno Therapeutics to Present Data Validating Target Biomarker at European Cancer Congress 2013

  September 30, 2013

   · 

  1 min read
• Number of Shares and Votes in Orexo AB

  September 30, 2013

   · 

  1 min read
• Drug Development

  Immunomedics, Inc. Reports Updated Results of Labetuzumab-SN-38 in Metastatic Colorectal Cancer

  September 30, 2013

   · 

  1 min read
• Drug Development

  Tesaro, Inc. Announces Initiation of Rolapitant IV Clinical Program

  September 30, 2013

   · 

  1 min read
• Business

  Trinity Biotech to Announce Third Quarter Fiscal Year 2013 Financial Results

  September 30, 2013

   · 

  1 min read
• Pharm Country

  NeoStem, Inc. to Present at Multiple October Conferences

  September 30, 2013

   · 

  1 min read
• Business

  BioRestorative Therapies, Inc. Engages Consulting Firm to Advance brtxDISC™ Program Delivery Device Through FDA Clearance Process

  September 30, 2013

   · 

  1 min read
• Genetown

  BCC Research Publishes a New Report on Global Markets for Smoking Cessation Medicines

  September 30, 2013

   · 

  3 min read
• Drug Development

  Alnylam Pharmaceuticals Completes Enrollment of Phase 2 Clinical Trial and Initiates Open-Label Extension (OLE) Study with ALN-TTR02, an RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of Transthyretin-Mediated Amyloidosis (ATTR)

  September 30, 2013

   · 

  1 min read
• Genetown

  Genzyme Corporation Announces Winners of Patient Advocacy Leadership (PAL) Awards

  September 30, 2013

   · 

  1 min read